Table 3.
Genotypic and allelic distribution frequencies of the SNPs in controls and CAD.
| SNP/Genotype | Control | CAD | p | OR (95% CI) | |
| rs1047286 | |||||
| AA | 3 (0.3%) | 3 (0.3%) | 0.951 | 1.051 (0.212–5.223) | |
| GA | 57 (6.4%) | 60 (6.4%) | 0.999 | 1 (0.687–1.454) | |
| GG | 837 (93.3%) | 881 (93.3%) | Reference | ||
| A | 63 (1.7%) | 66 (1.8%) | 0.979 | 1.005 (0.707–1.428) | |
| G | 1731 (47.0%) | 1822 (49.5%) | |||
| rs11569562 | |||||
| AA | 203 (22.7%) | 221 (23.4%) | 0.701 | 0.958 (0.771–1.191) | |
| GA | 462 (51.6%) | 494 (52.3%) | 0.742 | 0.97 (0.808–1.164 | |
| GG | 231 (25.8%) | 229 (24.3%) | Reference | ||
| A | 868 (48.4%) | 936 (49.6%) | 0.490 | 0.955 (0.84–1.087) | |
| G | 924 (51.6%) | 952 (50.4%) | |||
| rs163913 | |||||
| CC | 93 (10.5%) | 105 (11.2%) | 0.609 | 0.926 (0.689–1.244) | |
| TC | 415 (46.8%) | 440 (47.1%) | 0.907 | 0.989 (0.823–1.189) | |
| TT | 379 (42.7%) | 390 (41.7%) | Reference | ||
| C | 601 (33.9%) | 650 (34.8%) | 0.576 | 0.962 (0.839–1.103) | |
| T | 1173 (66.1%) | 1220 (65.2%) | |||
| rs2230199 | |||||
| CC | 4 (0.4%) | 2 (0.2%) | 0.378 | 2.11 (0.385–11.547) | |
| GC | 63 (7.0%) | 76 (8.1%) | 0.404 | 0.863 (0.61–1.221) | |
| GG | 830 (92.5) | 866 (91.7%) | Reference | ||
| C | 71 (4.0%) | 80 (4.2%) | 0.669 | 0.931 (0.672–1.291) | |
| G | 1723 (96.0%) | 1808 (95.8%) | |||
| rs2230204 | |||||
| CC | 265 (29.5%) | 309 (32.7%) | 0.140 | 0.862 (0.707–1.050) | |
| TC | 461 (51.4%) | 454 (48.1%) | 0.157 | 1.141 (0.95–1.37) | |
| TT | 171 (19.1%) | 181 (19.2%) | Reference | ||
| C | 991 (48.0%) | 1072 (52.0%) | 0.347 | 0.939 (0.825–1.07) | |
| T | 803 (49.6%) | 816 (50.4%) | |||
| rs2241393 | |||||
| CC | 308 (34.3%) | 312 (33.1%) | 0.560 | 1.059 (0.873–1.285) | |
| GC | 434 (48.4%) | 480 (50.8%) | 0.291 | 0.906 (0.755–1.088) | |
| GG | 155 (17.3%) | 152 (16.1%) | Reference | ||
| C | 1050 (58.5%) | 1104 (58.5%) | 0.974 | 1.002 (0.879–1.143) | |
| G | 744 (41.5%) | 784 (41.5%) | |||
| rs344550 | |||||
| CC | 120 (13.4%) | 115 (12.2%) | 0.442 | 1.113 (0.847–1.464) | |
| GC | 429 (47.8%) | 460 (48.7%) | 0.698 | 0.964 (0.803–1.158) | |
| GG | 348 (38.8%) | 369 (39.1%) | Reference | ||
| C | 669 (37.3%) | 690 (36.5%) | 0.640 | 1.032 (0.903–1.18) | |
| G | 1125 (62.7%) | 1198 (63.5%) | |||
| rs7257062 | |||||
| CC | 69 (7.7%) | 103 (10.9%) | **0.009 | 1.556 (1.116–2.170) | |
| CT | 385 (43.0%) | 417 (44.2%) | 0.216 | 1.129 (0.932–1.368) | |
| TT | 442 (49.3%) | 424 (44.9%) | Reference | ||
| C | 523 (29.2%) | 623 (33.0%) | *0.012 | 1.197 (1.041–1.377) | |
| T | 1271 (70.8%) | 1265 (67.0%) | |||
| rs8107911 | |||||
| AA | 691 (77.0%) | 735 (77.9%) | 0.672 | 0.954 (0.766–1.187) | |
| GA | 193 (21.5%) | 197 (20.9%) | 0.734 | 1.04 (0.831–1.3) | |
| GG | 13 (1.4%) | 12 (1.3%) | Reference | ||
| A | 1757 (88.9%) | 1667 (88.3%) | 0.543 | 1.064 (0.872–1.297) | |
| G | 219 (11.1%) | 221 (11.7%) | |||
SNP, single nucleotide polymorphism; CAD, coronary artery disease; OR, odds ratio; CI, confidence interval. *: p 0.05; **: p 0.01.